He looks like a sale person to me. Tone down is better. He had nothing new to share really.
It ran up too far too fast. Wait for it to down to the lower part of the trend line to add is better. Chasing biotech stocks are unsafe.
Solid performance, but I would not chase it (or any stock), Expect some selling on the news, or as Jim mentioned, a secondary is always possible, If you want in at a better price, sell puts, or wait for a dip. IMO